Nuzenio

Cost Biosimilars

Cost Biosimilars news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

340B Program Changes Could Shift Prescribing Toward Lower-Cost Biosimilars - ForbesForbes · Mon, 10 Aug 2026 16:49:13 GMTBiosimilars offer NC rare opportunity to save millions without cutting care - Pacific Research InstitutePacific Research Institute · Wed, 05 Aug 2026 20:48:16 GMTDoes Medicare’s drug price negotiation disincentivize biosimilar development? - Managed Healthcare ExecutiveManaged Healthcare Executive · Wed, 05 Aug 2026 17:20:24 GMTAmgen results show biosimilars and IRA pricing reshaping drug spend - Insurance BusinessInsurance Business · Wed, 05 Aug 2026 09:26:15 GMTFDA cuts new drug, biosimilar fees but hikes generics and device costs - CHOSUNBIZ - ChosunbizChosunbiz · Wed, 05 Aug 2026 01:00:00 GMTBiosimilars are driving down costs and increasing access to biologics - Managed Healthcare ExecutiveManaged Healthcare Executive · Tue, 04 Aug 2026 18:56:12 GMTYesafili, an Eylea biosimilar, launches with a price of $1,445 - Managed Healthcare ExecutiveManaged Healthcare Executive · Mon, 03 Aug 2026 18:46:35 GMTRand Paul's Biosimilar Drug Bill Could Cut Costs, Speed Patient Access - Reason MagazineReason Magazine · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 16:49:13 GMT340B Program Changes Could Shift Prescribing Toward Lower-Cost Biosimilars - Forbes
Wed, 05 Aug 2026 20:48:16 GMTBiosimilars offer NC rare opportunity to save millions without cutting care - Pacific Research Institute
Wed, 05 Aug 2026 17:20:24 GMTDoes Medicare’s drug price negotiation disincentivize biosimilar development? - Managed Healthcare Executive
Wed, 05 Aug 2026 09:26:15 GMTAmgen results show biosimilars and IRA pricing reshaping drug spend - Insurance Business
Wed, 05 Aug 2026 01:00:00 GMTFDA cuts new drug, biosimilar fees but hikes generics and device costs - CHOSUNBIZ - Chosunbiz
Tue, 04 Aug 2026 18:56:12 GMTBiosimilars are driving down costs and increasing access to biologics - Managed Healthcare Executive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cost Biosimilars.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.